James L. Kirkland

Active 1984–2025

243
Papers
58,968
Citations
110
h-index
230
i10-index

Citations

Citations per year for James L. Kirkland1985: 2 citations1986: 17 citations1990: 1 citations1992: 1 citations1993: 2 citations1994: 2 citations1995: 2 citations1997: 5 citations1998: 3 citations1999: 3 citations2000: 8 citations2001: 13 citations2002: 18 citations2003: 10 citations2004: 28 citations2005: 21 citations2006: 52 citations2007: 51 citations2008: 69 citations2009: 56 citations2010: 107 citations2011: 112 citations2012: 168 citations2013: 242 citations2014: 273 citations2015: 285 citations2016: 503 citations2017: 612 citations2018: 878 citations2019: 2,257 citations2020: 3,458 citations2021: 3,838 citations2022: 3,804 citations2023: 3,683 citations2024: 5,575 citations2025: 3,263 citations2026: 70 citations1987–1989: no citations, so these years are not shown1991: no citations, so this year is not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,847 citing papers, 25.4% of this breakdownChina: 3,140 citing papers, 16.5% of this breakdownUnited Kingdom: 1,167 citing papers, 6.1% of this breakdownItaly: 834 citing papers, 4.4% of this breakdownGermany: 815 citing papers, 4.3% of this breakdownSpain: 578 citing papers, 3% of this breakdownCanada: 574 citing papers, 3% of this breakdownJapan: 554 citing papers, 2.9% of this breakdownFrance: 525 citing papers, 2.7% of this breakdownAustralia: 413 citing papers, 2.2% of this breakdownNetherlands: 408 citing papers, 2.1% of this breakdownSouth Korea: 403 citing papers, 2.1% of this breakdown
0%25.4%Other 25.3%

Fields

  • Medicine60.7%
  • Biochemistry, Genetics and Molecular Biology25.4%
  • Immunology and Microbiology4.9%
  • Neuroscience4.3%
  • Engineering0.6%
  • Nursing0.6%
  • Other3.5%

Topics

  • Telomeres, Telomerase, and Senescence7%
  • Adipose Tissue and Metabolism3.9%
  • Genetics, Aging, and Longevity in Model Organisms2.9%
  • Adipokines, Inflammation, and Metabolic Diseases2.7%
  • Nutrition and Health in Aging1.8%
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms1.5%
  • Other80.2%

Coauthors

All papers

Open in search
  1. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul D. Robbins, Laura J. Niedernhofer, James L. Kirkland - Aging Cell 2015 cited by 2,425

  2. Senolytics improve physical function and increase lifespan in old age

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sundeep Khosla, Tamar Tchkonia, James L. Kirkland - Nature Medicine 2018 cited by 2,241

  3. Cellular senescence and senolytics: the path to the clinic

    Authors: , , - Nature Medicine 2022 cited by 1,038

  4. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders

    Authors: , , , , , , , - Nature 2011 cited by 3,688

  5. Cellular senescence: the good, the bad and the unknown

    Authors: , , , , - Nature Reviews Nephrology 2022 cited by 1,094

  6. Sarcopenia: Aging-Related Loss of Muscle Mass and Function

    Authors: , , , , , , , - Physiological Reviews 2018 cited by 1,709

  7. Senolytic drugs: from discovery to translation

    Authors: , - Journal of Internal Medicine 2020 cited by 1,119

  8. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yi Zhu, Tamar Tchkonia, James L. Kirkland - EBioMedicine 2019 cited by 1,286

  9. Cellular senescence mediates fibrotic pulmonary disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 1,571

  10. Fisetin is a senotherapeutic that extends health and lifespan

    Authors: , , , , , , , , , , , , , , , , , , , , , - EBioMedicine 2018 cited by 978

  11. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study

    Authors: , , , , , , , , , , - EBioMedicine 2019 cited by 1,188

  12. Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors

    Authors: , , , , , , , , , , , , , - Aging Cell 2015 cited by 1,106

  13. Strategies for targeting senescent cells in human disease

    Authors: , , , - Nature Aging 2021 cited by 483

  14. Targeting cellular senescence prevents age-related bone loss in mice

    Authors: , , , , , , , , , , , , , , , , , - Nature Medicine 2017 cited by 1,142

  15. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities

    Authors: , , , , - Journal of Clinical Investigation 2013 cited by 1,757

  16. Cellular senescence drives age-dependent hepatic steatosis

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 1,036

  17. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 892

  18. Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 247

  19. Cellular Senescence: A Translational Perspective

    Authors: , - EBioMedicine 2017 cited by 1,002

  20. New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463

    Authors: , , , , , , , , , - Aging 2017 cited by 726

  21. The role of cellular senescence in ageing and endocrine disease

    Authors: , , , - Nature Reviews Endocrinology 2020 cited by 518

  22. Senescent cell clearance by the immune system: Emerging therapeutic opportunities

    Authors: , , , - Seminars in Immunology 2018 cited by 480

  23. Whole‐body senescent cell clearance alleviates age‐related brain inflammation and cognitive impairment in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Aging Cell 2021 cited by 404

  24. Targeting senescent cells alleviates obesity‐induced metabolic dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Judith Campisi, Tamar Tchkonia, James L. Kirkland - Aging Cell 2019 cited by 669